Advertisement
Advertisement
U.S. Markets open in 2 hrs 28 mins
Advertisement
Advertisement
Advertisement
Advertisement

Amicus Therapeutics, Inc. (FOLD)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
10.53+0.62 (+6.26%)
At close: 04:00PM EST
10.42 -0.11 (-1.04%)
After hours: 05:56PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close9.91
Open10.43
Bid10.41 x 1000
Ask10.50 x 800
Day's Range10.01 - 10.62
52 Week Range8.40 - 22.18
Volume3,327,952
Avg. Volume2,523,146
Market Cap2.934B
Beta (5Y Monthly)1.20
PE Ratio (TTM)N/A
EPS (TTM)-0.90
Earnings DateFeb 28, 2022 - Mar 04, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est17.11
  • Zacks

    Amicus Therapeutics (FOLD) Stock Jumps 6.4%: Will It Continue to Soar?

    Amicus Therapeutics (FOLD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

  • GlobeNewswire

    Amicus Therapeutics Reports Preliminary 2021 Revenue and Provides 2022 Strategic Outlook and Revenue Guidance

    Full-Year 2021 Galafold® Revenue of ~$306M, Representing 17% YoY Growth Expect Double-Digit Growth (15-20%) of 2022 Galafold Revenue with $350M-$365M in Global Sales U.S. and EU Regulatory Reviews Underway for AT-GAA in Pompe Disease AT-GAA Global Launch Preparations Accelerating Cash Flow and Balance Sheet Sufficient to Achieve Self-Sustainability and Profitability by 2023 PHILADELPHIA, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnolog

  • GlobeNewswire

    Amicus Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference

    PHILADELPHIA, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will present at the 40th Annual J.P. Morgan Healthcare Conference, being held virtually on Wednesday, January 12, 2022 at 3:45 p.m. E.T. A live audio webcast of the presentation can also be accessed via the investors section of the Amicus Therapeutics corporate website at https://ir.amicusrx.com/events-and-presentations. About Amicus Therapeutics Amicus Therapeutics (Nasdaq: FOLD) i

Advertisement
Advertisement